Our global subsidiaries
We have three wholly-owned subsidiaries in USA, Germany and Philippines. Each of these subsidiaries complement our core strengths and strengthen our global presence.
BSV BIOSCIENCES, INC.
BSV BioSciences Inc has helped build a differentiated R&D capability for us. This research and drug development organisation is dedicated to early stage development of recombinant molecules. In-house molecular biology and recombinant expression capabilities were used to develop multiple cell lines for various products. BSV Biosciences Inc. has developed cell lines and lab scale processes for two biosimilar products and developed monoclonal Anti –D, rFSH, rHCG, mTIG, r-Anti D. These products are in various stages of clinical development and commercialization across geographies.
For more information please visit - www.bsvbio.com
BSV BIOSCIENCE GMBH
Our team in Germany undertakes research, development and manufacture of therapeutic proteins derived from natural sources.
BSVL’s Aachen-based API plant has developed state of the art isolation and purification methods for bulk pharmaceutical actives and finished formulations.
The plant manufactures urinary derived gonadotropins and highly purified gonadotropins.
For more information please visit - www.bsvbio.de
BSV Biosciences Philippines Inc
BSV Philippines began operations with a branch office in 2007 and subsequently set up a subsidiary in the year 2016. Over the years, BSV’s mainline products and in-licensed products have gained a strong foothold in the Philippines. These products fall largely in the speciality areas of Critical Care and Women’s Health. The 70+ member team promotes BSV’s therapeutic categories which include IVF, Gynaecology, Anti-fungals and Emergency Medicine.
For more information, please email: firstname.lastname@example.org